In 2019, only one in five new companies worldwide receiving venture financing was founded or co-founded by a woman, about the same percentage as in 2018. . . . → Read More: Women Founders Again Raise Small Share of Venture Funds
|
|||||
|
|
A biotechnology start-up enterprise plans to produce milk directly from mammary cells in the lab without crops, animals, or farms. . . . → Read More: New Company Developing Cell-Based Milk 
Microsoft Corp. plans to invest $1 billion over the next four years to create technologies for removing carbon from the atmosphere. . . . → Read More: Microsoft Launches $1 Billion Climate Fund 
An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals like DNA for reliably storing massive amounts of data. . . . → Read More: Synthetic DNA Studied for Mass Data Storage 
Venture capital deal-making in the U.S. declined in the fourth quarter of 2019, but biotechnology start-ups remained the most sought-after investment targets of any sector. . . . → Read More: Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot 
UPMC, the medical center affiliated with University of Pittsburgh, plans to invest $1 billion in life science advances, with spin-off companies as part of its strategy. . . . → Read More: UPMC to Invest $1 Billion in Medical Enterprises 
A gene therapy start-up is receiving an award resembling venture financing to advance its treatment for a rare inherited neuromuscular disorder to clinical trials. . . . → Read More: Venture Philanthropy Funds Rare Neuro Disease Trial 
A biotechnology company launched yesterday that plans to discover and develop therapies faster and at lower cost than many of today’s new drugs. . . . → Read More: New Biotech Aims to Bring Down Drug Prices 
A wireless electrode activated by light waves is being developed to connect with nerve cells in the brain that promises to make brain-computer connections safer. . . . → Read More: Light-Activated Brain Electrodes in Development 
A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds  Comments are closed  Finance  biomedical, biotechnology, equity, Europe, investment, licensing, life sciences, nanotechnology, pharmaceuticals, U.K., university, venture capital |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||